TriSalus Life Sciences to Host Virtual KOL Event to Discuss the TriNav Infusion System for the Treatment of Symptomatic Thyroid Disease on December 15, 2025 Dec 4, 2025 04:01PM
TriSalus Life Sciences Launches TriNav® XP Infusion System to Expand Options for Pressure-Enabled Drug Delivery™ Nov 18, 2025 08:00AM
TriSalus Life Sciences to Participate in Upcoming Investor Conferences Nov 11, 2025 04:05PM
TriSalus Life Sciences to Host Virtual KOL Event to Discuss the TriNav Infusion System for the Treatment of Uterine Fibroids on November 12, 2025 Nov 10, 2025 08:00AM
TriSalus Life Sciences to Host Third Quarter 2025 Financial Results Conference Call Oct 30, 2025 08:00AM
View Older Stories

Aug 28, 2025 08:00AM TriSalus Life Sciences to Participate in Upcoming September Investor Conferences
Aug 11, 2025 08:03AM TriSalus publishes thyroid embolization study results
Aug 11, 2025 08:00AM TriSalus Life Sciences Announces Publication of Safety and Efficacy Results for a Novel Pressure-Enabled Thyroid Embolization Technique
Jul 30, 2025 04:05PM TriSalus Life Sciences to Participate in the Canaccord Genuity 45th Annual Growth Conference
Jul 29, 2025 04:05PM TriSalus Life Sciences to Host Second Quarter 2025 Financial Results Conference Call
Jul 24, 2025 05:58PM TriSalus completes exchange offer for preferred stock
Jul 24, 2025 05:58PM TriSalus Life Sciences Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to Series A Convertible Preferred Stock
Jun 23, 2025 05:31PM TriSalus Life Sciences (TLSI) commences exchange offer
Jun 23, 2025 05:30PM TriSalus Life Sciences Announces Commencement of Exchange Offer and Consent Solicitation Relating to Series A Convertible Preferred Stock to Streamline Capital Structure
Jun 4, 2025 08:00AM TriSalus Life Sciences Announces the Launch of the TriNav FLX Infusion System
Mar 27, 2025 07:30AM TriSalus Life Sciences Reports Q4 and Full Year 2024 Financial Results and Provides Business Update
Mar 26, 2025 08:00AM TriSalus Life Sciences Announces New CMS HCPCS Code for TriNav® Infusion System Mapping
Mar 6, 2025 08:00AM TriSalus Life Sciences® Announces That Its Researchers Received Two JVIR Top Paper Awards for the Publication of “Intra-arterial Pressure-Enabled Drug Delivery™ Significantly Increases Penetratio
Feb 3, 2025 04:06PM TriSalus Life Sciences (TLSI) Appoints William J. Valle and Gary B. Gordon to its Board
Feb 3, 2025 04:05PM TriSalus Life Sciences Announces Key Appointments to Board of Directors
Feb 3, 2025 08:00AM TriSalus Life Sciences Announces Drawdown of $10 Million Tranche Under Credit Agreement with OrbiMed
Jan 23, 2025 08:01AM TriSalus Life Sciences (TLSI) Reports Prelim Q4 Results
Jan 23, 2025 08:00AM TriSalus Life Sciences Announces Preliminary Q4 and Full Year Unaudited 2024 Financial Results and Conference Call
Jan 9, 2025 08:00AM TriSalus Life Sciences® Announces Publication of Pre-Clinical Data Demonstrating Improved Delivery of Embospheres® to Liver Tumors using Pressure-Enabled Drug Delivery™ (PEDD™) via the TriNav®
Jan 8, 2025 08:05AM TriSalus Life Sciences (TLSI) Announces Leadership Changes
Jan 8, 2025 08:00AM TriSalus Announces Leadership Changes
Nov 14, 2024 08:00AM TriSalus Reports Q3 2024 Financial Results and Provides Business Update
Nov 11, 2024 07:00AM TriSalus Life Sciences® Forms Strategic Partnership with Geo-Med, LLC to Expand Access of the TriNav® Infusion System to U.S. Veterans with Liver Cancer
Nov 7, 2024 07:00AM TriSalus Life Sciences Launches TriNav® LV Infusion System and TriGuide™ Guiding Catheters, Expanding Portfolio of PEDD™ Devices for Improved Tumor Treatment
Oct 31, 2024 08:00AM TriSalus Life Sciences to Host Third Quarter 2024 Financial Results Conference Call
Oct 14, 2024 04:05PM TriSalus Life Sciences to Participate in the 2024 Maxim Healthcare Virtual Summit
Sep 26, 2024 07:02AM TriSalus Life Sciences (TLSI) Appoints Riad Salem to its Board
Sep 26, 2024 07:00AM TriSalus Life Sciences Announces Appointment of Riad Salem, M.D., to its Scientific Advisory Board
Sep 23, 2024 07:03AM TriSalus Life Sciences (TLSI) Announces Journal of Vascular and Interventional Radiology Publication of Data that Demonstrate Improved Therapeutic Delivery of Glass Microspheres to Solid Tumors With P
Sep 23, 2024 07:00AM TriSalus Announces Journal of Vascular and Interventional Radiology Publication of Data that Demonstrate Improved Therapeutic Delivery of Glass Microspheres to Solid Tumors With PEDD™ Method via the
Aug 15, 2024 08:00AM TriSalus Reports Q2 2024 Financial Results and Business Update
Aug 1, 2024 07:00AM TriSalus Life Sciences to Host Second Quarter 2024 Financial Results Conference Call
Jul 1, 2024 04:00PM TriSalus Life Sciences Announces Completion of Exchange Offer and Consent Solicitation
Jun 26, 2024 05:45PM TriSalus Life Sciences Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to Warrants
Jun 3, 2024 07:00AM TriSalus Life Sciences Highlights Clinical Data from Phase 1b PERIO-02 Trial, Studying Delivery of Nelitolimod via Pressure-Enabled Drug Delivery in Patients with Hepatocellular Carcinoma or Intrahepa
May 24, 2024 06:06AM TriSalus Life Sciences (TLSI) Commences Exchange Offer and Consent Solicitation Relating to Warrants
May 24, 2024 06:05AM TriSalus Life Sciences Announces Commencement of Exchange Offer and Consent Solicitation Relating to Warrants
May 15, 2024 08:00AM TriSalus Reports Q1 2024 Financial Results and Business Update
May 7, 2024 07:03AM TriSalus Life Sciences (TLSI) Appoints Liselotte Hyveled to its Board
May 7, 2024 07:00AM TriSalus Life Sciences Appoints Liselotte Hyveled to its Board of Directors
May 6, 2024 04:58PM TriSalus Life Sciences to Host First Quarter 2024 Financial Results Conference Call
Apr 30, 2024 04:36PM TriSalus Life Sciences (TLSI) Secures $50M Debt Financing with OrbiMed
Apr 30, 2024 04:35PM TriSalus Life Sciences Secures up to $50 million of Debt Financing with OrbiMed to Support TriNav® Infusion System Growth Initiatives
Apr 1, 2024 08:00AM TriSalus Reports Q4 and Full Year 2023 Financial Results and Business Update
Mar 26, 2024 08:00AM TriSalus Life Sciences Technology Featured in Two Presentations at the Society of Interventional Radiology Annual Scientific Meeting
Mar 21, 2024 08:00AM TriSalus Life Sciences Announces Oral Presentations at the Upcoming 2024 Society of Interventional Radiology (SIR) Annual Scientific Meeting
Mar 11, 2024 05:15PM TriSalus Life Sciences Announces Q4 Conference Call and Preliminary and Unaudited Q4 and Full Year 2023 Financial Results
Mar 7, 2024 07:02AM TriSalus Life Sciences (TLSI) Receives Approval for “Nelitolimod” as the Nonproprietary Drug Name for SD-101
Mar 7, 2024 07:00AM TriSalus Life Sciences Receives Approval from the World Health Organization and the American Medical Association’s Adopted Name Council for “Nelitolimod” as the Nonproprietary Drug Name for SD-1
Feb 29, 2024 07:00AM TriSalus Life Sciences Announces Real-World Data Demonstrating the Ability of TriNav® to Successfully Treat Patients with Higher Disease Burden and to Improve Delivery of Therapeutics to Liver Tumors
View Older Stories